Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
N = 837) comprising obese/overweight individuals presenting with a range of metabolic syndrome features but not overt T2D or ischemic heart disease (IHD) (Supplementary Table 1)
Free online consultation One-on-one consultation with bilingual counselors / doctors Same-day shipping Available depending on the time of your order Fully online process From consultation to delivery, all on your smartphone Weight loss journey ~1st month ~1st month Start with 0.6mg / injection Adjust the dosage as directed by your physician Body begins to acclimate ~6 months ~6 months Appetite decreases Start seeing weight loss effects (average weight loss of 3.38kg at a dose of 1.8mg*) ~12 months ~12 months Body feels satisfied with less food Noticeably bigger weight loss effects (average loss of 6.5kg at a dose of 3.0mg*) How it works Book online Create an account, answer a short medical questionnaire, and talk directly to a counselor or book an appointment
Key highlights Semaglutide is a popular and effective GLP-1 receptor agonist manufactured by Novo Nordisk
Are compounded semaglutide and tirzepatide as effective as brand-name versions
